ISO/IEC 17025: 2017 Accredited
Access to Information
Jobs
Tenders
e-systems
Search
Home
About us
Who we are
Departments
Executive management
The Board of Directors
Technical Committees
E-Services
PV reporting forms
ADR reporting system
News
All news
Press releases
Product Recalls and Alerts
Downloads
The PMRA Act, 2019
Regulations
Guidelines
Applications forms
Fee schedule
Strategic Plan
Registers
Premises register
Personnel register
Products register
Clinical trial register
Contact us
Access to Information
Contact us online
Media Enquiry
Feedback and complaints
Report Corruption
FAQs
You are here :
Home
» Press releases
Press releases
Regulatory enforcement action against non-compliant pharmaceutical business premises and personnel
Public Notice – Commencement of baseline survey on public awareness of PMRA mandate and functions
Notice of release of August 2024 registration examination results
PMRA statement on the study claiming Malawi has highest prevalence of substandard medicines
WHO Alert on Falsified (contaminated) Oxymorphone Hydrochloride 40mg tablets
PMRA statement on WHO alert on falsified OZEMPIC (semaglutide)
Joint-media-statement-on-spread-of-false-social-media-claims-about-HIV-cure-1
Alert notice on recall of two batches Benylin paediatric cough syrup
Joint PMRA-Macra statement on enforcement of regulations on advertisement of TCM products
PMRA & MBTS joint statement on recall of Single Blood Bags
PMRA & MCM joint statement on WHO alert on substandard cough syrups
Public statement on presence of counterfeit Epiderm Cream and Epiderm Lotion
Public notice – Product recall of Actrapid Soluble Insulin 100IU
Notice of release of August 2024 registration examination results